Moderna’s COVID-19 vaccine is effective in young people between 12 and 17, according to results from phase two of three of the biopharmaceutical company’s study.
Moderna’s COVID-19 vaccine is effective in young people between 12 and 17, according to results from phase two of three of the biopharmaceutical company’s study.